Education
About Us
Working with TipRanks
Follow Us
Nexgel, Inc. (NXGL)
:NXGL
NXGL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.10 - $5.10
Previous CloseN/A
Volume27.00K
Average Volume (3M)44.55K
Market Cap
$25.57M
Enterprise Value$22.06M
Total Cash (Recent Filing)$725.00K
Total Debt (Recent Filing)$2.65M
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Nov 18, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding8,067,580
10 Day Avg. Volume44,467
30 Day Avg. Volume44,545
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue1.89
Enterprise Value/Gross Profit4.94
Enterprise Value/Ebitda-8.84
Forecast
1Y Price Target
$6.00Price Target Upside150.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Partnership And FundingNexGel expanded its partnership with STADA for commercializing additional products in North America, with STADA providing an upfront of $1M to support product launches and promotional work.
Product PipelineNexGel has additional products in the pipeline with market opportunities expected to be larger than the current product, Histasolv.
Revenue GrowthManagement reiterated 2025 revenue guidance of at least $13M, up 50%+ y/y.
Bears Say
Operating ExpensesOperating expenses were slightly greater than expected but expected to decline in 2H25.
NexGel Inc News
NXGL FAQ
What was Nexgel, Inc.’s price range in the past 12 months?
Nexgel, Inc. lowest stock price was $2.10 and its highest was $5.10 in the past 12 months.
What is Nexgel, Inc.’s market cap?
Nexgel, Inc.’s market cap is $25.57M.
When is Nexgel, Inc.’s upcoming earnings report date?
Nexgel, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 49 days.
How were Nexgel, Inc.’s earnings last quarter?
Nexgel, Inc. released its earnings results on Aug 12, 2025. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.02.
Is Nexgel, Inc. overvalued?
According to Wall Street analysts Nexgel, Inc.’s price is currently Undervalued.
Does Nexgel, Inc. pay dividends?
Nexgel, Inc. does not currently pay dividends.
What is Nexgel, Inc.’s EPS estimate?
Nexgel, Inc.’s EPS estimate is -0.08.
How many shares outstanding does Nexgel, Inc. have?
Nexgel, Inc. has 8,067,580 shares outstanding.
What happened to Nexgel, Inc.’s price movement after its last earnings report?
Nexgel, Inc. reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went down -11.439%.
Which hedge fund is a major shareholder of Nexgel, Inc.?
Currently, no hedge funds are holding shares in NXGL
NexGel Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (150.00% Upside)
$6.00 (150.00% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.39%
12-Months-Change
Fundamentals
Return on Equity
-66.08%
Trailing 12-Months
Asset Growth
-0.66%
Trailing 12-Months
Company Description
Nexgel, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
NXGL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong growth trajectory with significant revenue and margin improvements. New product launches and strategic partnerships like STADA contribute positively, but ongoing EBITDA losses and reliance on key partnerships like AbbVie present challenges. Overall, the sentiment remains cautious but optimistic.View all NXGL earnings summariesNXGL Stock 12 Month Forecast
Average Price Target
$6.00
▲(150.00% Upside)
Technical Analysis
Ownership Overview
16.39% Insiders
1.55% Mutual Funds
4.53% Other Institutional Investors
76.38% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---